Finance

Lists
DHER34:BVMF
Danaher Corporation Bdr
39,36 R$
0,00%
(0,00) 1D
9 ოქტ, 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for DHER34...
Open
39,18 R$
High
39,36 R$
Low
39,18 R$
Mkt. cap
154,52 მლრ.
Avg. vol.
2,36 ათ.
Volume
404,00
52-wk high
45,87 R$
52-wk low
27,94 R$
Shares outstanding
702,99 მლნ.
No. of employees
59 ათ.
Open
39,18 R$
High
39,36 R$
Low
39,18 R$
Mkt. cap
154,52 მლრ.
Avg. vol.
2,36 ათ.
Volume
404,00
52-wk high
45,87 R$
52-wk low
27,94 R$
Shares outstanding
702,99 მლნ.
No. of employees
59 ათ.
News stories
From web sources and news partners
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corporation Bdr
CEOრაინერ ემ ბლერ
Employees59 ათ.
Founded1969
Headquarters-
SectorHealth care
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
6,05 მლრდ.
6,84 მლრდ.
5,95 მლრდ.
6,26 მლრდ.
Cost of goods sold
2,53 მლრდ.
2,86 მლრდ.
2,36 მლრდ.
2,61 მლრდ.
Cost of revenue
2,53 მლრდ.
2,86 მლრდ.
2,36 მლრდ.
2,61 მლრდ.
Research and development expenses
378,00 მლნ.
438,00 მლნ.
387,00 მლნ.
412,00 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,89 მლრდ.
2,03 მლრდ.
1,84 მლრდ.
2,01 მლრდ.
Operating expense
2,27 მლრდ.
2,46 მლრდ.
2,23 მლრდ.
2,42 მლრდ.
Total operating expenses
4,80 მლრდ.
5,32 მლრდ.
4,59 მლრდ.
5,03 მლრდ.
Operating income
1,26 მლრდ.
1,52 მლრდ.
1,36 მლრდ.
1,24 მლრდ.
Other non operating income
-
-87,00 მლნ.
-
-
EBT including unusual items
1,08 მლრდ.
1,37 მლრდ.
1,24 მლრდ.
1,08 მლრდ.
EBT excluding unusual items
1,19 მლრდ.
1,39 მლრდ.
1,33 მლრდ.
1,19 მლრდ.
Income tax expense
168,00 მლნ.
190,00 მლნ.
206,00 მლნ.
208,00 მლნ.
Effective tax rate
15,61%
13,84%
16,68%
19,29%
Other operating expenses
-
-
-
-
Net income
908,00 მლნ.
1,20 მლრდ.
1,03 მლრდ.
870,00 მლნ.
Net profit margin
15,00%
17,51%
17,29%
13,89%
Earnings per share
1,89
2,23
2,06
1,94
Interest and investment income
3,00 მლნ.
13,00 მლნ.
27,00 მლნ.
61,00 მლნ.
Interest expense
-67,00 მლნ.
-55,00 მლნ.
-63,00 მლნ.
-107,00 მლნ.
Net interest expenses
-64,00 მლნ.
-42,00 მლნ.
-36,00 მლნ.
-46,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,88 მლრდ.
2,14 მლრდ.
1,99 მლრდ.
1,90 მლრდ.
Gain or loss from assets sale
-9,00 მლნ.
9,00 მლნ.
-
-
AI content may include mistakes. Learn more
Google აპები